Genoptix Company Description
Genoptix is promoting optimal health. The biotechnology company is a specialized laboratory service provider founded in 1999. It analyzes blood and tissue samples in order to diagnose diseases such as leukemia and markets those services to community-based hematologists and oncologists treating malignancies of the blood and bone marrow, as well as other types of cancer. Its key service offerings are COMPASS (short for Comprehensive Assessment) and CHART (a service offering introduced in 2007). Genoptix was started by Dr. Tina Nova, who also co-founded San Diego-based life science companies Ligand Pharmaceuticals and Nanogen.
View the Comprehensive Company Description for Genoptix
The Company Description provides a historical perspective of Genoptix's organization from inception to current status.
Produced by Hoover's in-house editorial team, the Company Description tracks ownership transitions, company progress via mergers and acquisitions, major growth milestones, and strategic initiatives, to provide a holistic view of Genoptix's evolution in the marketplace.
